A detailed new map of the human kidney revealed a previously unrecognized form of diabetic kidney disease (DKD) marked by clusters of immune cells—specifically B cells—that are linked to faster disease progression. The findings could help guide more targeted treatments in the future, according to study results led by researchers at the Perelman School of Medicine at the University of Pennsylvania and published today in Nature.

Consuming a plant-based diet may help lower levels of a key marker of inflammation in the body, according to analysis of clinical trials led by University of Warwick researchers. 

Findings could help identify Ebola and, ultimately, save lives.

Johns Hopkins Medicine researchers say they have identified molecular pathways controlled by the protein RhoA in club cells — a specialized population of epithelial cells that exclusively lines the inner and outer surfaces of the lung’s small airways, with known roles in immune regulation and airway repair — during allergen-induced airway inflammation. Through a series of translational mouse and cell culture experiments, the research team has demonstrated how RhoA can be selectively targeted to potentially prevent asthma-related complications. 

The American Hospital Association (AHA) and the West Health Institute today announced a new three-year initiative to help hospitals and health systems operationalize and scale proven technologies across care environments to improve patient outcomes and support care teams.

A new paper from researchers at the University of Kansas looks at extreme heat events in the United States, arguing a combination of inadequate data and unclear delineation of responsibility among government agencies leaves the nation unprepared for a hotter climate.

A study in Current Pharmaceutical Analysis has confirmed that a ketamine-xylazine-butorphanol (KXB) sedative for llamas and alpacas is chemically and microbiologically stable beyond its current expiration limit. The validated HPLC method showed over 90% drug potency after three months, with no microbial growth, supporting the 28-day beyond-use date.